Literature DB >> 17049794

Diastereomeric and enantiomeric high-performance liquid chromatographic separation of synthetic anisodamine.

Li-Min Yang1, Yi-Fan Xie, Hong-Zhuan Chen, Yang Lu.   

Abstract

In order to investigate the enantiomeric pharmacokinetics and biotransformation of synthetic anisodamine (654-2), a cholinoceptor antagonist widely used in clinic in China, it has been preparatively separated into two racemates (I and II) by using ZORBAX Eclipse XDB-C18 column. The diastereo- and/or enantioseparations of 654-2, I and II were carried out by HPLC using CHIRALPAK AD-H as chiral stationary phase (CSP) and acetonitrile-2-propanol-DEA 97:3:0.1 (v/v/v) as mobile phase. The methods were optimized by studying mobile phase modifiers, concentration of modifier and column temperature. The HPLC method for the simultaneous separation of two pairs of enantiomers of 654-2 has been validated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049794     DOI: 10.1016/j.jpba.2006.09.006

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.

Authors:  Wei-Wei Zhang; Zu-Peng Xu; Yong-Yao Cui; Hao Wang; Ming-Ke Song; Juan Li; Bi-Yun Shao; Zheng Xia; Hong-Zhuan Chen
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.